ACHILLION PHARMACEUTICALS INC 4
4 · ACHILLION PHARMACEUTICALS INC · Filed Jan 23, 2015
Insider Transaction Report
Form 4
Deshpande Milind
EVP and CSO
Transactions
- Sale
Common Stock
2015-01-21$15.00/sh−100,000$1,500,000→ 0 total - Exercise/Conversion
Common Stock
2015-01-21$3.02/sh+100,000$302,000→ 100,000 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-01-21−100,000→ 300,000 totalExercise: $3.02Exp: 2023-12-17→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]These options were granted on December 17, 2013 and May 23, 2014 with 25% of the shares vesting on December 17, 2014 and an additional 6.25% vesting at the end of each three-month period thereafter.